Evidence map›Paper›PMID 38270183›Full record

ArticleEmerging infectious diseases2024

Integrating Veterinary Diagnostic Laboratories for Emergency Use Testing during Pandemics

Natasha F Hodges, McKenzie Sparrer, Tyler Sherman, Treana Mayer, Danielle R Adney, Izabela Ragan, Molly Carpenter, Christie Mayo, Tracy L Webb

Abstract read
In one paragraph

Article in Emerging infectious diseases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Natasha F Hodges
McKenzie Sparrer
Tyler Sherman
Treana Mayer
Danielle R Adney
Izabela Ragan
Molly Carpenter
Christie Mayo
Tracy L Webb

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The SARS-CoV-2 pandemic showed limitations in human outbreak testing. Veterinary diagnostic laboratories (VDLs) possess capabilities to bolster emergency test capacity. Surveys from 26 participating VDLs found human SARS-CoV-2 testing was mutually beneficial, including One Health benefits. VDLs indicated testing >3.8 million human samples during the pandemic, which included some challenges.

Indexed as

COVID-19 TestingOne HealthDisease OutbreaksHumansLaboratoriesPandemicsSARS-CoV-2bioterrorism and preparednesscoronavirusesCOVID-19disease outbreaksemergency use testingOne Healthpandemicsrespiratory infectionsSARS-CoV-2United Statesveterinary diagnostic laboratoriesveterinary diagnostic servicesviruses

Identifiers

PMID38270183
PMCPMC10826766

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.